ANTHROMOLECULE Trademark

Trademark Overview

On Tuesday, April 4, 2023, a trademark application was filed for ANTHROMOLECULE with the United States Patent and Trademark Office. The USPTO has given the ANTHROMOLECULE trademark a serial number of 97981248. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Saturday, February 14, 2026. This trademark is owned by Montai Health, Inc.. The ANTHROMOLECULE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of nutritional supplements, therapeutics, and pharmaceuticals
anthromolecule

General Information

Serial Number97981248
Word MarkANTHROMOLECULE
Filing DateTuesday, April 4, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateSaturday, February 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2024

Trademark Statements

Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of nutritional supplements, therapeutics, and pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 27, 2023
Primary Code042
First Use Anywhere DateThursday, October 31, 2024
First Use In Commerce DateThursday, October 31, 2024

Trademark Owner History

Party NameMONTAI THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameMONTAI THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameMontai Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, April 7, 2023NEW APPLICATION ENTERED
Thursday, April 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 30, 2023ASSIGNED TO EXAMINER
Sunday, December 31, 2023NON-FINAL ACTION WRITTEN
Sunday, December 31, 2023NON-FINAL ACTION E-MAILED
Sunday, December 31, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 25, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, March 25, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, May 8, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, September 29, 2024ASSIGNED TO EXAMINER
Monday, November 25, 2024ASSIGNED TO EXAMINER
Monday, November 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 18, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 24, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 24, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 14, 2025TEAS REQUEST TO DIVIDE RECEIVED
Thursday, August 14, 2025TEAS STATEMENT OF USE RECEIVED
Friday, February 13, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 14, 2025DIVISIONAL REQUEST RECEIVED
Saturday, February 14, 2026DIVISIONAL PROCESSING COMPLETE
Thursday, August 14, 2025USE AMENDMENT FILED
Saturday, February 14, 2026STATEMENT OF USE PROCESSING COMPLETE
Saturday, February 14, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, February 14, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

anthromolecule research scientific development nutritional biotechnology supplements therapeutics pharmaceuticals field others